Background
Glucose-insulin-potassium (GIK) administration during cardiac surgery
inconsistently improves myocardial function, perhaps because hyperglycemia
negates the beneficial effects of GIK. The hyperinsulinemic normoglycemic
clamp (HNC) technique may better enhance the myocardial benefits of GIK. We
extended previous GIK investigations by: 1) targeting normoglycemia while
administering a glucose-insulin-potassium infusion (HNC); 2) using improved
echocardiographic measures of myocardial deformation, specifically
myocardial longitudinal strain and strain rate; and, 3) assessing activation
of glucose metabolic pathways.
Methods
100 patients having aortic valve replacement for aortic stenosis were
randomly assigned to HNC (high-dose insulin with concomitant glucose
infusion titrated to normoglycemia) versus standard therapy (insulin
treatment if glucose >150 mg/dL). Our primary outcomes were left
ventricular longitudinal strain and strain rate, assessed using
speckle-tracking echocardiography. Right atrial tissue was analyzed for
activation of glycolysis/pyruvate oxidation and alternative metabolic
pathways.
Results
Time-weighted mean glucose concentrations were lower with HNC
(127±19 mg/dL) than standard care (177±41 mg/dL;
P<0.001). Echocardiographic data were adequate in 72
patients for strain analysis and 67 patients for strain rate analysis. HNC
did not improve myocardial strain, with an HNC minus standard therapy
difference of −1.2 (97.5%CI: −2.9, 0.5)%;
P=0.11. Strain rate was significantly better,
but by a clinically unimportant amount: −0.16 (−0.30,
−0.03) sec−1, P = 0.007.
There was no evidence of increased glycolytic, pyruvate oxidation, or
hexosamine biosynthetic pathway activation in right atrial samples (n
= 20, HNC; 22, standard therapy).
Conclusions
Administration of glucose and insulin while targeting normoglycemia
during aortic valve replacement did not meaningfully improve myocardial
function.